Monitoring the evolution, spread and transmission of SARS-CoV-2 through whole genome sequencing to enable fast genotype to phenotype prediction

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:11 publications

Grant number: 10150062010005

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    dr. Prof MPG Koopmans
  • Research Location

    N/A
  • Lead Research Institution

    Erasmus MC
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics
  • Research Subcategory

    Pathogen morphology, shedding & natural history
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable

Abstract

During this project we mapped the evolution and spread of SARS-CoV-2 in the Netherlands. We used this information in different phases of the pandemic: in the first phase we used it to estimate the extent of the pandemic in the Netherlands, then we mapped the evolution of the virus in mink and attempted to control the spread of to contain the virus between mink farms. In the current phase of the pandemic, we are looking at reinfections and viral evolution in patients infected with SARS-CoV-2 for a long time. Collectively, these findings have contributed to increasing our knowledge regarding the course of the pandemic and these results can be used to be better prepared for future variants and a faster translation between the findings in the lab and the possible impact of these findings to decide. Interim results This project has so far delivered the following interim results: - An article about transmission across national borders at the beginning of the COVID-19 pandemic in Limburg. - An article (still under peer review) on tracking SARS-CoV-2 variants B.1.1.7 (British variant) and B.1.351 (South African variant). - An article about the effect of vaccines on SARS-CoV-2 variant B.1.1.7 (British variant) and B.1.351 (South African variant). More information about research into corona and COVID-19 at www.zonmw.nl/coronaonderzoek

11 Publications linked via Europe PMC

Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.

Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.

Population-based screening in a municipality after a primary school outbreak of the SARS-CoV-2 Alpha variant, the Netherlands, December 2020-February 2021.

Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person.

Defining the risk of SARS-CoV-2 variants on immune protection.

Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands.

Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay.

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.